Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 10,583 shares at $74.69 ($763K) on 2024-03-01, disclosed to the SEC on 2024-03-04.
Scheduled sale ($763k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.97 | 366 | $27K | 3.5% |
| 2 | $73.04 | 506 | $37K | 4.8% |
| 3 | $73.54 | 439 | $32K | 4.2% |
| 4 | $73.59 | 591 | $43K | 5.7% |
| 5 | $74.69 | 363 | $27K | 3.6% |
| 6 | $74.78 | 351 |
| $26K |
| 3.4% |
| 7 | $71.55 | 7,967 | $570K | 74.7% |
| Total | $72.08 avg | 10,583 | $763K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |